Rising Chronic Disease Rates Portend Unsustainable Costs


By Kenneth E. Thorpe

12 percent of Americans suffer from five or more chronic conditions, such as high blood pressure, heart disease, and diabetes. This fraction of the population accounts for 41 percent of total health care spending.

If we don't do more to prevent people from acquiring chronic disease, the resulting health care bills could blow a gaping hole in the federal budget.

A new study conducted by RAND Health and supported by my organization, the Partnership to Fight Chronic Disease, shows just how costly it is to treat the severely ill.

In 2014, the latest data available, 32 percent of those with five or more chronic conditions visited an emergency department at least once. ER visits cost over $1,200 on average.

The sickest patients also require more prescriptions. In 2014, patients with five or more chronic conditions filled nearly six times the number of prescriptions as people with one or two chronic diseases.

Chronic disease prevents people from living independently. More than half of those with five or more chronic conditions report having physical limitations that affect their daily lives.

As a result, patients have to cut back on work or ask someone to help them. More than 34 million Americans provide unpaid care to adults who are older than 50. This leads to a loss in worker productivity that could cost society $794 billion by 2030.

If we hope to save lives and avoid such staggering costs, we must undertake key reforms to help patients manage and prevent chronic diseases.

First, policymakers need to work together to ensure that care is affordable and accessible. A third of privately-insured Americans recently reported receiving a "surprise" medical bill, one in which their health insurance plan paid less than what they expected. And many insurers have started dropping certain prescriptions from their coverage, leaving patients to either try a new drug or to pay for their current drug out-of-pocket.

When patients can't access the care they need, they get sicker -- and health care costs rise. Improving medication adherence alone could save America more than $105 billion a year.

Second, we ought to expand programs proven to prevent chronic diseases. For instance, the Diabetes Prevention Program, which is offered by private insurers, helps patients at risk of developing diabetes improve their diet and exercise more. The program has worked tremendously well -- patients aged 60 or older who made lifestyle changes through the program reduced their risk of developing diabetes by 71 percent. Medicare will cover it for those at risk and age 65 and older starting in 2018, but if Medicare offered the program to at-risk adults aged 60-64, it could save $7 billion more.

Altogether, increasing access to health care and promoting behavioral changes could save society $116 billion a year.

Finally, America needs to encourage the development of new treatments and medicines. In 2016, there were 93 medicines in development for Alzheimer's disease, more than 170 for diabetes, and more than 130 for mental illnesses. Fostering the development of medicines and treatments that target chronic disease would save millions of lives and save $418 billion a year.

If current trends continue, chronic diseases will claim millions of American lives and cost us trillions of dollars. To lower that toll, we need to promote prevention efforts and improve access to recommended care for those who are already diagnosed.

Kenneth E. Thorpe is a professor of health policy at Emory University and the chairman of the Partnership to Fight Chronic Disease.

More Resources


11/22/2024
Mighty Casey Has Struck Out
Democrat Bob Casey Jr. has served in public office in this state since taking the oath of office as the state auditor general in 1997.

more info


11/22/2024
Gaetz's Implosion Shows Resistance Is Not Futile
Trump's first nominations reveal the serious fractures in his coalition - which can be used to weaken him

more info


11/22/2024
Building a Better Ground Game Critical to Trump's Victory
American Majority Action turned out low-participation voters in battleground States to help Trump and fellow Republicans to victory.

more info


11/22/2024
The Myth That Could Cost Democrats the Next Election
Progressives staying home (almost certainly) didn't cost Kamala Harris the election.

more info


11/22/2024
Jussie Smollett, the Chicago Way and MAGA


more info


11/22/2024
It's Over--Somebody Needs To Tell Bragg's Office


more info


11/22/2024
Congress Must Seize Post-Chevron Opportunity


more info


11/22/2024
Former NIH Director Francis Collins on Trump, RFK Jr.


more info


11/22/2024
How the Left Betrayed the Jews


more info


11/22/2024
I Mean, Seriously Jaguar?
In the aftermath of Trump's victory, the ad already looks like a period piece. But aside from that - I mean, seriously? says Guardian columnist Marina Hyde

more info


11/22/2024
November 22, 1963: JFK and the Futility of Blame


more info


11/22/2024
Dems Have Lost the Plot in the View of Working-Class Voters
The road back to the working class.

more info


11/22/2024
The Trump Counterrevolution Is a Return to Sanity
We are witnessing a historic counterrevolution after Trump's victory, far different from his first election in 2016.

more info


11/22/2024
Harris Disappointed Gen Z
Trump made gains among young voters in 2024, leaving Democrats wondering why.

more info


11/22/2024
Democrats Need Their Own Donald Trump
There may be five stages of grief, but there's usually just one when it comes to political defeat - pretend to soul-search, then carry on as if nothing happened.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."